S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty

Z. Káposzta, Andrew Clifton, Jane Molloy, John F. Martin, Hugh S. Markus

Research output: Article

41 Citations (Scopus)

Abstract

Background-The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S-Nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. Methods and Results-Sixteen patients undergoing carotid angioplasty and stenting for symptomatic ≥70% internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95% at 0 to 3 hours and 100% at 6 hours (P=0.007 and P=0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group. Conclusions-S-Nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.

Original languageEnglish
Pages (from-to)3057-3062
Number of pages6
JournalCirculation
Volume106
Issue number24
DOIs
Publication statusPublished - dec. 10 2002

Fingerprint

S-Nitrosoglutathione
Angioplasty
Carotid Stenosis
Stroke
Placebos
Aspirin
Heparin
Doppler Ultrasonography
Nitric Oxide Donors
Economic Inflation
Middle Cerebral Artery
Therapeutics
Platelet Aggregation
Blood Platelets

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty. / Káposzta, Z.; Clifton, Andrew; Molloy, Jane; Martin, John F.; Markus, Hugh S.

In: Circulation, Vol. 106, No. 24, 10.12.2002, p. 3057-3062.

Research output: Article

Káposzta, Z. ; Clifton, Andrew ; Molloy, Jane ; Martin, John F. ; Markus, Hugh S. / S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty. In: Circulation. 2002 ; Vol. 106, No. 24. pp. 3057-3062.
@article{2eb036bcbd094f198eff758470c6f1ca,
title = "S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty",
abstract = "Background-The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S-Nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. Methods and Results-Sixteen patients undergoing carotid angioplasty and stenting for symptomatic ≥70{\%} internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95{\%} at 0 to 3 hours and 100{\%} at 6 hours (P=0.007 and P=0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group. Conclusions-S-Nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.",
keywords = "Angioplasty, Carotid arteries, Embolism, Nitric oxide, Platelets",
author = "Z. K{\'a}poszta and Andrew Clifton and Jane Molloy and Martin, {John F.} and Markus, {Hugh S.}",
year = "2002",
month = "12",
day = "10",
doi = "10.1161/01.CIR.0000041251.07332.28",
language = "English",
volume = "106",
pages = "3057--3062",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "24",

}

TY - JOUR

T1 - S-Nitrosoglutathione reduces asymptomatic embolization after carotid angioplasty

AU - Káposzta, Z.

AU - Clifton, Andrew

AU - Molloy, Jane

AU - Martin, John F.

AU - Markus, Hugh S.

PY - 2002/12/10

Y1 - 2002/12/10

N2 - Background-The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S-Nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. Methods and Results-Sixteen patients undergoing carotid angioplasty and stenting for symptomatic ≥70% internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95% at 0 to 3 hours and 100% at 6 hours (P=0.007 and P=0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group. Conclusions-S-Nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.

AB - Background-The major complication of carotid angioplasty is embolic stroke, which may occur after balloon inflation and deflation or in the early postintervention period. Platelet adhesion and aggregation to the angioplasty site with subsequent embolization seems to plays a major role in early postangioplasty embolization and stroke. During this period, asymptomatic embolic signals can be detected in patients by transcranial Doppler ultrasound despite aspirin and heparin treatment. S-Nitrosoglutathione (GSNO) is a nitric oxide donor that appears to have relative platelet specificity. We evaluated its effectiveness in reducing embolization after carotid angioplasty. Methods and Results-Sixteen patients undergoing carotid angioplasty and stenting for symptomatic ≥70% internal carotid artery stenosis were randomized in a double-blind manner to GSNO or placebo given after surgery for 90 minutes. All patients were pretreated with aspirin and given heparin for 24 hours after the procedure. Transcranial Doppler recordings were made from the ipsilateral middle cerebral artery for 1 hour before treatment and at 0 to 3, 6, and 24 hours after treatment. GSNO resulted in a rapid reduction in the frequency of embolic signals of 95% at 0 to 3 hours and 100% at 6 hours (P=0.007 and P=0.01 versus placebo, respectively). In the placebo group, 2 patients experienced ipsilateral stroke after the angioplasty. No cerebrovascular events occurred in the GSNO group. Conclusions-S-Nitrosoglutathione was highly effective in rapidly reducing the frequency of embolic signals after endovascular treatment for symptomatic high-grade carotid stenosis.

KW - Angioplasty

KW - Carotid arteries

KW - Embolism

KW - Nitric oxide

KW - Platelets

UR - http://www.scopus.com/inward/record.url?scp=0037058825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037058825&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000041251.07332.28

DO - 10.1161/01.CIR.0000041251.07332.28

M3 - Article

VL - 106

SP - 3057

EP - 3062

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 24

ER -